Short summary
Pharma = sourcing externally
Long summary
Pharma companies, for instance, are increasingly sourcing new molecular entities from startups because the variety of innovative strategies means more chances of success
Citation
Geilinger, Ulrich, and Chandra Leo. HBM New Drug Approval Report: Analysis of FDA New Drug Approvals in 2018 (and Multi-Year Trends). Zug, Switzerland: HBM Partners, 2019.
Source
Report
file
tag
Report